semaglutide pancreatitis law firm in louisiana office Novo Nordisk is suing Eli Lilly over its GLP-1 semaglutide pancreatitis lawyer in louisiana

Patients experiencing changes in sexual health or serious side effects (severe abdominal pain, signs of pancreatitis or gallbladder disease) should consult their GP promptly

Foundayo (orforglipron): A non-peptide small-molecule GLP-1 in pill form, approved by the FDA in 2026

Comparative safety data shows acute kidney injury was listed in 0.47% of tirzepatide adverse event reports versus 1.07% of semaglutide reports in the FDA Adverse Event Reporting System (FAERS), with the reporting odds ratio favoring tirzepatide

This can be dangerous if patients already have a heart condition, but frightening in any case

Liver problems could be the cause of hypoglycemia episodes

McMackin, C